Health Benefits of Chronic vs. Acute Exercise in Overweight Adults
Not Applicable
Completed
- Conditions
- Obesity
- Registration Number
- NCT01452087
- Lead Sponsor
- University of Michigan
- Brief Summary
Compare the effects of single session of exercise vs. chronic exercise training on key risk factors associated with Metabolic Syndrome (e.g., glucose tolerance, blood lipid profile, and blood pressure) in overweight adults.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
- Body Mass Index: 27-34 kg/m2;
- Regular exercisers(≥4 days/wk of aerobic exercise;
- 30-60min/session at moderate and vigorous intensities);
- Non-exercisers (no regularly planned exercise/physical activity);
- Women must have regularly occurring menses and must be premenopausal.
Exclusion Criteria
- Pregnant or lactating;
- Evidence/history of cardiovascular or metabolic disease;
- Currently taking medications known to affect lipid or glucose metabolism.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method oral glucose tolerance test 2 hour
- Secondary Outcome Measures
Name Time Method Resting Metabolic Rate 20-30 min
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie chronic exercise's impact on metabolic syndrome risk factors in overweight adults?
How does acute exercise compare to chronic exercise in improving glucose tolerance and lipid profiles in individuals with obesity?
Which biomarkers are associated with differential responses to acute versus chronic exercise interventions in metabolic syndrome?
What adverse events are reported in long-term exercise training programs for overweight adults and how are they managed?
Are there combination approaches involving exercise and pharmacotherapy that enhance metabolic syndrome outcomes in obese populations?
Trial Locations
- Locations (1)
Substrate Metabolism Laboratory
🇺🇸Ann Arbor, Michigan, United States
Substrate Metabolism Laboratory🇺🇸Ann Arbor, Michigan, United States